CANY
MDXG icon

Caxton Associates (New York)’s MiMedx Group MDXG Stock Holding History

Caxton Associates (New York)’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-132,155
Closed -$1.02M – 551
2024
Q1 		$1.02M Buy
+132,155
New +$1.06M 0.06% 216
2014
Q1 		– Sell
-50,000
Closed -$437K – 230
2013
Q4 		$437K Buy
+50,000
New +$306K 0.01% 191

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Caxton Associates (New York)'s MDXG Position: Q2 2024 in Review

Caxton Associates (New York) sold out of MiMedx Group (MDXG) in Q2 2024, closing a stake of 132,155 shares — an estimated $1.02M sold.

Caxton Associates (New York) first reported a position in MDXG in Q4 2013 and held it in 2 quarters. The position peaked at $1.02M in Q1 2024. 202 funds tracked by Wall St. Rank hold MDXG as of Q2 2024.

  • Caxton Associates (New York) reported no remaining MiMedx Group position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 132,155 MiMedx Group shares in Q2 2024, an estimated $1.02M.
  • Caxton Associates (New York) first reported a position in MiMedx Group in Q4 2013 and held it in 2 quarters.
  • Caxton Associates (New York)'s MiMedx Group position peaked at $1.02M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.